Product
Brilacidin
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19Status: Completed, Estimated PCD: 2021-07-01